China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	22,673	18,992	18,276	13,948	12,508	13,614
Market Cap Growth	35.18%	3.92%	31.03%	11.51%	-8.12%	7.94%
Enterprise Value	21,374	16,381	16,124	11,180	9,405	11,081
Last Close Price	22.08	18.25	17.25	12.39	10.84	11.53
PE Ratio	16.83	14.03	15.14	13.81	11.25	11.40
Forward PE	12.90	12.46	15.32	11.70	9.97	14.94
PS Ratio	2.20	1.86	1.90	1.53	1.47	1.45
PB Ratio	2.23	1.61	1.61	1.33	1.33	1.57
P/TBV Ratio	3.34	2.24	2.29	1.76	1.69	2.04
P/FCF Ratio	20.96	18.50	20.54	16.42	12.36	11.36
P/OCF Ratio	13.30	11.65	12.91	10.40	9.20	9.46
PEG Ratio	0.99	0.99	0.99	0.99	0.99	0.99
EV/Sales Ratio	2.07	1.60	1.68	1.23	1.11	1.18
EV/EBITDA Ratio	9.77	7.83	9.07	7.55	6.08	6.96
EV/EBIT Ratio	14.34	11.09	13.03	10.81	8.02	9.00
EV/FCF Ratio	19.76	15.96	18.13	13.16	9.29	9.25
Debt / Equity Ratio	0.07	0.03	0.03	0.01	-	0.01
Debt / EBITDA Ratio	0.34	0.15	0.16	0.04	-	0.04
Debt / FCF Ratio	0.66	0.30	0.33	0.07	-	0.05
Asset Turnover	0.65	0.67	0.67	0.70	0.72	0.87
Inventory Turnover	2.82	2.66	2.42	2.74	2.59	3.26
Quick Ratio	1.19	1.85	1.79	2.08	2.02	2.03
Current Ratio	1.59	2.42	2.48	2.75	2.55	2.58
Return on Equity (ROE)	12.07%	11.47%	11.32%	9.79%	11.23%	12.86%
Return on Assets (ROA)	5.63%	6.03%	5.36%	4.95%	6.19%	7.13%
Return on Capital (ROIC)	7.67%	7.78%	6.98%	6.49%	8.09%	9.09%
Earnings Yield	5.94%	7.02%	6.46%	6.71%	8.04%	7.75%
FCF Yield	4.77%	5.40%	4.87%	6.09%	8.09%	8.80%
Dividend Yield	0.90%	1.41%	3.35%	3.87%	2.68%	2.64%
Payout Ratio	83.33%	22.95%	67.94%	32.34%	31.77%	28.35%
Buyback Yield / Dilution	0.71%	0.99%	0.74%	-0.00%	-0.00%	0.01%
Total Shareholder Return	1.61%	2.40%	4.09%	3.87%	2.68%	2.64%

Source: S&P Capital IQ. Standard template. Financial Sources.